A new report shows that anti-TNF therapy does not appear to increase the risk of congestive heart failure in patients with rheumatoid arthritis, and may even have a slight protective effect, according to research presented.
Patients with rheumatoid arthritis experience a reduction in C-reactive protein, a blood test marker for cardiovascular disease, while taking atorvastatin, as well as lower cholesterol and triglyceride blood levels, according to research.
There appears to be no association between depression, sensitivity to pain stimulus and how pain is processed in the brain in fibromyalgia patients with and without clinical depression, according to research.
Prolonged remission, that is, no evidence of disease activity or treatment for at least five consecutive years, is rare in patients with lupus, according to research presented this week.
The role of lung transplantation for people who suffer from scleroderma, an unusual condition that affects 300,000 Americans, has long been a point of contention in the medical community but that might change, according to research.
Ultrasound may be a promising alternative for the diagnosis and evaluation of patients who show symptoms of carpal tunnel syndrome, according to research presented this week.
African Americans are twice as likely as Caucasians to suffer from an increase in the severity of knee osteoarthritis, according to research presented this week.
Millions of Americans suffer from "dry eye" associated with autoimmune diseases, and for many, over-the-counter eye drops don't work sufficiently. These patients may find relief using cyclosporine, according to research.
While the risk of lymphoma is increased in people with rheumatoid arthritis, there does not appear to be a link between methotrexate and anti-TNF therapies and an increase in the risk of developing lymphomas, according to research.
Activity and work limitations for people with rheumatoid arthritis and their associated productivity costs can now be measured in actual dollar amounts, which means that the effect of improvement through treatment can be projected, according to research.
Doxycycline may be a promising new treatment for people with knee osteoarthritis because of its effect on slowing the progression of structural damage and because it helps reduce the frequency of increases in joint pain that occur over time, according to research.
While survival rates from hip fracture improved from 1990-2000, black men and women are increasingly likely to suffer from this debilitating health problem, according to research presented this week.
The American College of Rheumatology Research and Education Foundation announced today that Abbott Laboratories has donated $3.5 million to an endowment program that will ensure the continued recruitment of rheumatologists and rheumatology health professionals for years to come.
Greater access to a rheumatologist, a specialist who treats arthritis, may mean better care and an earlier start of treatment for patients with arthritis, according to research.
Initial aggressive drug treatment may prevent work disability in patients with early stage rheumatoid arthritis, according to research.
Patients on low-dose aspirin therapy who had been prescribed a non-steroidal anti-inflammatory drug (NSAID) in the first year following a heart attack were less likely to suffer a recurrent acute heart attack in that year compared to those who had not been prescribed an NSAID, according to research.
A new study shows that highly effective therapies for rheumatoid arthritis may be cost-effective in the treatment of this expensive disease by improving patients functional status, their ability to work, and by lessening the other costs of treating patients, according to research.
Arthritis patients are as effectively managed in nurse-led clinics as they are in clinics led by new doctors, and they may even be more satisfied with their care, according to research.
Health maintenance organizations strive to lower the cost of rheumatoid arthritis care by reducing the use of new medications, not by lowering the number of hospital admissions or surgeries, according to research.
Rituximab may treat rheumatoid arthritis in novel way by more selectively targeting the B cells, which make antibodies that contribute to the disease process, according to research.
Targeting an at-risk population through interactive education may result in a significantly reduced chance of contracting Lyme disease, according to research.
Updated guidelines for the management of rheumatoid arthritis have been published in the an official journal of the American College of Rheumatology.
People with rheumatoid arthritis who take methotrexate but continue to have active arthritis may have further improvement in arthritis control with the addition of a new injectable treatment called anakinra.
People with rheumatoid arthritis who are already taking methotrexate may have further improvement in arthritis control with the addition of a new injectable treatment called adalimumab, according to research presented at the ACR Annual Scientific Meeting.
People with ankylosing spondylitis who are treated with etanercept, an anti TNF therapy which has been used to treat rheumatoid arthritis, may experience significant improvement in pain and mobility.
Drinking decaffeinated coffee may increase your risk developing rheumatoid arthritis if you're an older woman, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.
CDP870, a potential new anti-TNF therapy, shows promising results in the treatment of rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.
Two investigational therapies show promise in treating rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.
It appears that most of the aspirin-type medications referred to as NSAIDs do not decrease the risk of heart attacks with the exception of one, according to research presented at the American College of Rheumatology Annual Scientific Meeting in San Francisco, California.
Treating rheumatoid arthritis early on is the key to better outcomes and decreased disability, according to several sets of research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.
A Tai Chi exercise program may result in less pain and fewer difficulties with daily activities, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 10 - 15 in San Francisco, California.
Treprostinil, a structural analogue of naturally occurring prostacyclin, has been shown to be safe and effective in the treatment of patients with pulmonary hypertension associated with various forms of connective tissue disease.
Due to major advancements in the understanding and management of glucocorticoid-induced osteoporosis, the American College of Rheumatology has updated its guidelines after only five years.
The symptoms of fibromyalgia may be the result of a central nervous system that "remembers" pain sensations for an abnormally long time, according to research presented at the American College of Rheumatology Annual Scientific Meeting in Philadelphia.
An abnormally slow rate of growth during childhood may mean a greater chance of a hip fracture decades later, according to research presented at the American College of Rheumatology Annual Scientific Meeting Oct. 29 ñ Nov. 2 in Philadelphia, Pennsylvania.
Parents' perceptions of their children's health status may be a self-fulfilling prophecy, according to research presented at the American College of Rheumatology Annual Scientific Meeting Oct. 29 -- Nov. 2 in Philadelphia, Pennsylvania.
Rheumatoid arthritis may join heart disease and lung cancer as diseases for which cigarette smoking increases risk, according to research presented at the American College of Rheumatology Annual Scientific Meeting Oct. 29 ñ Nov. 2 in Philadelphia, Pennsylvania.
Sports injuries in youth can lead to arthritis at a relatively young age, according to research presented at the American College of Rheumatology Annual Scientific Meeting Oct. 29 ñ Nov. 2 in Philadelphia, Pennsylvania.
New guidelines for the medical management of osteoarthritis will be published in the September issue of Arthritis & Rheumatism. Due to major advancements in the understanding of this disease, the ACR has updated its guidelines after only five years.
Arthritis patients use dozens of techniques to manage their disease, but drugstore remedies and health providers still top the list, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Traditional non-steroidal anti-inflammatory drugs (NSAIDs), commonly used to treat the symptoms of arthritis, prevent blood clotting just as much as a daily dose of aspirin does, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Mortality and complication rates of total hip replacements decrease as hospitals' and surgeons' procedure volume increases. according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Glucosamine sulfate, a dietary supplement sold over the counter in the United States and as a prescription drug in Europe, reduces the signs and symptoms of osteoarthritis of the knee, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Etanercept, a soluble TNF-alpha receptor approved last year for adult rheumatoid arthritis, is safe and effective for treatment of juvenile rheumatoid arthritis, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Alendronate significantly improves bone mass in children and adolescents with secondary osteoporosis, a complication of chronic steroid use. Steroids are widely used in the treatment of noninfectious inflammatory conditions, such as rheumatic disease, according to research presented at the American College of Rheumatology Annual Scientific Meeting Nov. 13--17 in Boston.
Acupuncture, an ancient East Asian therapy using needles to redirect channels of energy in the body, does not appear to be effective for patients suffering from rheumatoid arthritis, researchers reported at the peer-reviewed American College of Rheumatology National Scientific Meeting Nov. 8-12 in San Diego, Calif.
Two-thirds of women surveyed did not understand that estrogen replacement therapy is an important way to combat osteoporosis, researchers reported at the peer-reviewed American College of Rheumatology National Scientific Meeting Nov. 8-12 in San Diego, Calif.
Results of a twin study show that genetic factors have a substantial influence on the occurrence of osteoarthritis of the hip, researchers reported at the peer-reviewed American College of Rheumatology National Scientific Meeting Nov. 8-12 in San Diego, Calif.
Researchers have discovered a possible link between two factors suspected of contributing to the onset of juvenile rheumatoid arthritis (JRA), they reported at the peer-reviewed American College of Rheumatology National Scientific Meeting Nov. 8-12 in San Diego, Calif.
Methotrexate, prescribed by rheumatologists for decades, reduces the risk of death from rheumatoid arthritis complications by up to 50 percent, researchers reported at the peer-reviewed American College of Rheumatology National Scientific Meeting Nov. 8-12 in San Diego, Calif.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right